Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Gliknik Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10933
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Gliknik Inc (Gliknik) is a biopharmaceutical company that develops therapies for patients suffering from cancer and immune disorders. The company’s pipeline products include biropepimut-S (GL-0817) and GL-2045. Its biropepimut-S is an engineered peptide immunomodulator targeted against important epitopes within the cancer protein MAGE-A3. Gliknik designs recombinant GL-2045 to mimic the structure and efficacy of the very small and variable portion of the pooled human blood product IVIG, which is an active fraction in treating autoimmune disorders. The company partners with pharmaceutical industries. Gliknik is headquartered in Baltimore, Maryland, the US.

Gliknik Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9
Gliknik Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gliknik Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Gliknik Raises Funds through Venture Financing 11
Gliknik Raises US$2.8 Million In Venture Financing 12
Gliknik Raises US$10 Million In Series B Financing 13
Licensing Agreements 14
Gliknik Enters Into Licensing Agreement With Pfizer For GL-2045 14
Gliknik Inc – Key Competitors 15
Gliknik Inc – Key Employees 16
Gliknik Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Gliknik Inc, Pharmaceuticals & Healthcare, Key Facts 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9
Gliknik Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Gliknik Raises Funds through Venture Financing 11
Gliknik Raises US$2.8 Million In Venture Financing 12
Gliknik Raises US$10 Million In Series B Financing 13
Gliknik Enters Into Licensing Agreement With Pfizer For GL-2045 14
Gliknik Inc, Key Competitors 15
Gliknik Inc, Key Employees 16

List of Figures
Gliknik Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Gliknik Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Gliknik Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Gliknik Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Gliknik Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vipul Ltd:企業の戦略・SWOT・財務情報
    Vipul Ltd - Strategy, SWOT and Corporate Finance Report Summary Vipul Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Yasuhara Chemical Co Ltd (4957):企業の財務・戦略的SWOT分析
    Yasuhara Chemical Co Ltd (4957) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pierrel Spa (PRL)-製薬・医療分野:企業M&A・提携分析
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • Fortinet Inc (FTNT):企業の財務・戦略的SWOT分析
    Fortinet Inc (FTNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Seaboard Corporation:企業の戦略・SWOT・財務情報
    Seaboard Corporation - Strategy, SWOT and Corporate Finance Report Summary Seaboard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Panasonic Corp (6752)
    Panasonic Corp (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • YTL Power International Bhd (YTLPOWR):企業の財務・戦略的SWOT分析
    YTL Power International Bhd (YTLPOWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Magnis Energy Technologies Ltd (MNS):企業の財務・戦略的SWOT分析
    Magnis Energy Technologies Ltd (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • China CAMC Engineering Co Ltd (002051):企業の財務・戦略的SWOT分析
    Summary China CAMC Engineering Co Ltd (CAMC), a subsidiary of China National Machinery Industry Corp, is a construction company that offers engineering, procurement and construction services. The company designs and constructs shipyard, turnkey project in pulp plant, agricultural equipment industria …
  • DairiConcepts, L.P:企業の戦略・SWOT・財務情報
    DairiConcepts, L.P - Strategy, SWOT and Corporate Finance Report Summary DairiConcepts, L.P - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Invetech Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Invetech Pty Ltd (Invetech), a subsidiary of Danaher Corp is a manufacturer of custom automation systems. The company offers services which include product development, instrument development, custom automation and contract manufacturing. It specializes in applied sciences, automated measure …
  • Gritstone Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gritstone Oncology Inc (Gritstone) is a cancer immunotherapy company which focuses on the development of personalized cancer therapeutics. The company primarily concentrates on identifying and deploying the therapeutic neo-antigens from individual patients’ tumors for the development of nove …
  • Xcel Energy Inc:企業の発電所・SWOT分析2018
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Hemanext:医療機器:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • The Law Debenture Corp plc (LWDB):企業の財務・戦略的SWOT分析
    Summary The Law Debenture Corp plc (LDC) is a financial service provider that offers investment trust and independent fiduciary services. The company’s services include corporate trusts, pension trusteeship, whistle blowing services and governance services. It offers financial services such as trust …
  • Damodar Valley Corp:電力:M&Aディール及び事業提携情報
    Summary Damodar Valley Corp (DVC) is a government owned multi-purpose river valley project. It generates, transmits, and supplies electricity; mines for and produces coal; manages water and conserves soil; and provides consultancy services. The company produces energy using thermal and hydro sources …
  • Eastern Company SAE:企業の戦略・SWOT・財務情報
    Eastern Company SAE - Strategy, SWOT and Corporate Finance Report Summary Eastern Company SAE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HOK Group, Inc.:企業の戦略・SWOT・財務情報
    HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary HOK Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆